EP0737471A3 - Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue - Google Patents
Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue Download PDFInfo
- Publication number
- EP0737471A3 EP0737471A3 EP96400513A EP96400513A EP0737471A3 EP 0737471 A3 EP0737471 A3 EP 0737471A3 EP 96400513 A EP96400513 A EP 96400513A EP 96400513 A EP96400513 A EP 96400513A EP 0737471 A3 EP0737471 A3 EP 0737471A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- earth metal
- alkaline earth
- tnf
- metal salts
- obtained therefrom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9504265A FR2732600B1 (fr) | 1995-04-10 | 1995-04-10 | Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique et/ou dermatologique et composition obtenue |
FR9504267A FR2732601B1 (fr) | 1995-04-10 | 1995-04-10 | Utilisation d'un sel de metal alcalino-terreux pour le traitement des rougeurs cutanees d'origine neurogene |
FR9504265 | 1995-04-10 | ||
FR9504264 | 1995-04-10 | ||
FR9504268A FR2732602B1 (fr) | 1995-04-10 | 1995-04-10 | Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique ou pharmaceutique pour traiter les prurits |
FR9504264A FR2732599B1 (fr) | 1995-04-10 | 1995-04-10 | Utilisation de sels de metaux alcalino-terreux comme inhibiteurs de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
FR9504267 | 1995-04-10 | ||
FR9504268 | 1995-04-10 | ||
FR9510980 | 1995-09-20 | ||
FR9510980 | 1995-09-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0737471A2 EP0737471A2 (fr) | 1996-10-16 |
EP0737471A3 true EP0737471A3 (fr) | 2000-12-06 |
Family
ID=27515606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96400513A Ceased EP0737471A3 (fr) | 1995-04-10 | 1996-03-12 | Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue |
Country Status (4)
Country | Link |
---|---|
US (1) | US5851556A (fr) |
EP (1) | EP0737471A3 (fr) |
CA (1) | CA2173689C (fr) |
NO (1) | NO323573B1 (fr) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6203803B1 (en) | 1994-12-14 | 2001-03-20 | Societe L'oreal S.A. | Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
US6139850A (en) * | 1994-12-21 | 2000-10-31 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
US7404967B2 (en) | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
US6416760B2 (en) * | 1995-01-26 | 2002-07-09 | Societe L'oreal | Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin |
FR2742054B1 (fr) * | 1995-12-06 | 1998-01-09 | Synthelabo | Compositions pharmaceutiques contenant un agent anti-inflammatoire et des ceramides vegetales |
US6406709B1 (en) | 1997-05-29 | 2002-06-18 | Nidaria Technology Ltd. | Method for inhibiting nematocyst discharge |
US6338837B1 (en) * | 1997-05-29 | 2002-01-15 | Nidaria Technology Ltd. | Compositions and methods for inhibiting nematocyst discharge |
FR2774285B1 (fr) * | 1998-02-03 | 2001-06-15 | Roche Posay Lab Pharma | Utilisation d'une composition cosmetique pour le traitement et la prevention de la rosacee |
US5972993A (en) * | 1998-03-20 | 1999-10-26 | Avon Products, Inc. | Composition and method for treating rosacea and sensitive skin with free radical scavengers |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
US20030077301A1 (en) * | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
US20030072814A1 (en) * | 1999-12-16 | 2003-04-17 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of warts |
DE60235989D1 (de) | 2001-06-26 | 2010-05-27 | Amgen Fremont Inc | Antikörper gegen opgl |
US20030059450A1 (en) | 2001-09-24 | 2003-03-27 | Maibach Howard I. | Method and topical formulation for treating skin conditions associated with aging |
NO20014746D0 (no) * | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
US7081247B2 (en) * | 2002-05-20 | 2006-07-25 | Nidaria Technology Ltd. | Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting |
US20030232094A1 (en) * | 2002-06-12 | 2003-12-18 | Fuller Peter E. | Composition and method for the treatment of skin irritations |
US6943197B2 (en) | 2002-06-21 | 2005-09-13 | Howard I. Maibach | Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses |
US6821523B2 (en) * | 2002-06-21 | 2004-11-23 | Dermatrends, Inc. | Topical administration of pharmacologically active bases in the treatment of warts |
WO2004011017A1 (fr) * | 2002-07-31 | 2004-02-05 | Himalayan International Institute Of Yoga Science And Philosophy | Solutions d'irrigation nasale et procedes d'utilisation associes |
DK1556020T3 (da) | 2002-08-12 | 2009-06-22 | Birkir Sveinsson | Anvendelse af CGRP-antagonistforbindelser til behandling af psoriasis |
EP1578782A4 (fr) | 2002-12-30 | 2007-09-12 | Amgen Inc | Polytherapie a facteurs costimulants |
US20070053994A1 (en) * | 2003-03-27 | 2007-03-08 | Egil Jellum | Anti-inflammatory treatment |
EP1622630B1 (fr) * | 2003-05-07 | 2012-08-29 | Osteologix A/S | Composition contenant entre autres du strontium pour la prophylaxie et/ou le traitement de pathologies des cartilages et/ou des os |
PL1745791T3 (pl) | 2003-05-07 | 2013-11-29 | Osteologix As | Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu |
KR20060014433A (ko) * | 2003-06-04 | 2006-02-15 | 에버사이츠, 엘엘씨 | 신규의 피부의학 조성물 |
DE10347824B4 (de) * | 2003-10-10 | 2011-08-11 | Lach, Hans-Joachim, Dr., 79331 | Pharmazeutische oder kosmetische Zusammensetzung zur Behandlung der Haut |
ES2342461T3 (es) * | 2003-10-17 | 2010-07-07 | Oy Neurofood Ab | Agente de estroncio no radiactivo para tratar el cancer. |
US7258875B2 (en) * | 2003-12-04 | 2007-08-21 | Chiou Consulting, Inc. | Compositions and methods for topical treatment of skin infection |
US20080167513A1 (en) * | 2004-02-26 | 2008-07-10 | Osteologlx A/S | Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions |
PT1732575E (pt) * | 2004-02-26 | 2011-03-23 | Osteologix As | Compostos que contêm o estrôncio para uso na prevenção ou tratamento de condições ósseas necróticas |
FR2872047B1 (fr) * | 2004-06-23 | 2007-06-15 | Oreal | Composition pour peaux sensibles associant cation mineral et probiotique(s) |
MXPA06015184A (es) | 2004-06-23 | 2007-11-22 | Nestec Sa | Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas. |
US20060045858A1 (en) * | 2004-08-26 | 2006-03-02 | Fuller Peter E | Composition and method for reducing harmful effects of ultraviolet radiation impinging on the skin |
EP1731137A1 (fr) * | 2005-06-08 | 2006-12-13 | Nestec S.A. | Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles |
WO2006037922A1 (fr) * | 2004-10-04 | 2006-04-13 | L'oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles |
EP1642570A1 (fr) | 2004-10-04 | 2006-04-05 | L'oreal | Composition cosmétique et/ou dermatologique pour peaux sensibles |
ES2525495T3 (es) * | 2004-10-08 | 2017-07-26 | Forward Pharma A/S | Composiciones farmacéuticas de liberación controlada que comprenden un éster del ácido fumárico |
US7300649B2 (en) | 2005-02-11 | 2007-11-27 | Genepharm, Inc. | Cosmetic and cosmeceutical compositions for restoration of skin barrier function |
FR2889057B1 (fr) * | 2005-08-01 | 2008-07-18 | Oreal | Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches |
GB0517043D0 (en) * | 2005-08-19 | 2005-09-28 | York Pharma Plc | Improvements in pharmaceutical compositions |
ES2664421T3 (es) | 2005-11-14 | 2018-04-19 | Teva Pharmaceuticals International Gmbh | Anticuerpo antagonista dirigido contra un péptido relacionado con el gen de la calcitonina |
WO2007060381A1 (fr) * | 2005-11-24 | 2007-05-31 | Santosolve As | Préparations contenant du strontium et leur application à des méthodes de traitement cosmétique |
GB0617191D0 (en) * | 2006-08-31 | 2006-10-11 | York Pharma Plc | Improvements in pharmaceutical compositions |
WO2009006701A1 (fr) * | 2007-07-12 | 2009-01-15 | Peter O'gorman | Médicament topique |
FR2919501B1 (fr) * | 2007-08-02 | 2010-12-31 | Oreal | Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees |
FR2920304B1 (fr) | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
FR2920305B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
MX2010002247A (es) * | 2007-09-04 | 2010-05-17 | Oreal | Uso de una combinacion de hesperidina y de un microorganismo para influir en la funcion de barrera de la piel. |
FI122450B (fi) * | 2007-12-28 | 2012-01-31 | Neurofood Ab Oy | Koostumus steriilin inflammaation hoitoon |
ES2689322T3 (es) | 2008-03-04 | 2018-11-13 | Teva Pharmaceuticals International Gmbh | Métodos para tratar el dolor crónico |
AU2008274908B2 (en) * | 2008-07-11 | 2014-08-14 | Whipbird Pain Relief Pty Ltd | Topical medicament |
EP2379063B2 (fr) | 2009-01-09 | 2021-02-24 | Fwp Ip Aps | Formule pharmaceutique comportant un ou plusieurs esters d'acide fumarique dans une matrice erosive |
FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
BR112012004464B8 (pt) | 2009-08-28 | 2021-05-25 | Labrys Biologics Inc | uso de um anticorpo antagonista anti-cgrp para preparar uma composição farmacêutica para tratar e/ou prevenir dor visceral e/ou um ou mais sintomas de dor visceral, em que a dor visceral está associada á cistite intersticial (ic), e dita composição farmacêutica |
US8409628B2 (en) * | 2010-02-04 | 2013-04-02 | Penguin IP Holdings, Inc. | Methods and compositions for oxygenation of skin to treat skin disorders |
EP2530068A1 (fr) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | Nouveaux sels de strontium, leur synthèse et leur utilisation dans le traitement de l'ostéoporose |
CA3026687A1 (fr) | 2012-03-21 | 2013-09-26 | Galleon Labs Llc | Complexes contenant du strontium administre par voie topique pour le traitement de la douleur, du prurit et de l'inflammation |
US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
EP3119431B1 (fr) | 2014-03-21 | 2024-01-24 | Teva Pharmaceuticals International GmbH | Anticorps antagonistes dirigés contre le peptide lié au gène de la calcitonine et leurs procédés d'utilisation |
WO2016060626A1 (fr) * | 2014-10-16 | 2016-04-21 | Geli̇şi̇m Maki̇na-Madenci̇li̇k-Mühendi̇sli̇k Ti̇c. Ve San. Ltd. Şti̇. | Procédés et compositions pour prévenir et traiter l'hyperhidrose |
WO2016130686A1 (fr) * | 2015-02-11 | 2016-08-18 | Cosmederm Bioscience, Inc. | Composés de strontium stables à haute concentration et formulations pour application topique |
FR3034667B1 (fr) * | 2015-04-13 | 2018-09-07 | Laboratoires Dermatologiques D'uriage | Composition cosmetique et/ou dermatologique contre l'acne |
US11235002B2 (en) | 2015-08-21 | 2022-02-01 | Galleon Labs Llc | Strontium based compositions and formulations for pain, pruritus, and inflammation |
PE20191148A1 (es) | 2016-09-23 | 2019-09-02 | Teva Pharmaceuticals Int Gmbh | Tratamiento de la migrana refractaria |
US11433119B2 (en) | 2016-11-18 | 2022-09-06 | Nepsone Ehf | Methods of treating inflammatory skin disorders |
US10391121B2 (en) | 2017-05-03 | 2019-08-27 | BioPharmX, Inc. | Magnesium chloride composition for dermatological use |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1072355A (en) * | 1964-06-17 | 1967-06-14 | Michael Collin | Antiseptic and anti-pruretic solution containing camphor |
US3519711A (en) * | 1967-09-01 | 1970-07-07 | Robert E Svigals | Composition and method of treating pruritic conditions of the skin |
US4477439A (en) * | 1981-04-13 | 1984-10-16 | Walter J. Monacelli | Treatment of irritated and excoriated areas around the stoma of ostomy patients |
EP0217975A1 (fr) * | 1985-10-08 | 1987-04-15 | Psori-Med Ag | Mélange de sels pour le traitement du psoriasis et autres maladies de la peau |
EP0451300A1 (fr) * | 1990-04-10 | 1991-10-16 | Romuald Dr. Kowalski | Composition contenant une dispersion colloidale de sulfate de baryum |
US5296476A (en) * | 1989-09-08 | 1994-03-22 | Henderson Esther G | Skin care compositions |
DE4315866C1 (de) * | 1993-05-12 | 1994-05-05 | Wogepharm Gmbh | Äußerliche Zubereitungen zur Therapie von Hauterkrankungen mit Photosensibilisatoren |
WO1996019184A1 (fr) * | 1994-12-21 | 1996-06-27 | Cosmederm Technologies | Formulations et procedes pour diminuer l'irritation de la peau |
WO1996019228A1 (fr) * | 1994-12-21 | 1996-06-27 | Cosmederm Technologies | Formulations et procedes pour diminuer l'irritation de la peau |
WO1996019182A1 (fr) * | 1994-12-21 | 1996-06-27 | Cosmederm Technologies | Formulations et procedes pour diminuer l'irritation de la peau |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE35991B1 (en) * | 1971-01-22 | 1976-07-21 | Comprehensive Pharmaceuticals | Improvements in or relating to the treatment of diseases of the skin and mucosa |
US3772431A (en) * | 1972-09-21 | 1973-11-13 | W Mlkvy | Effervescent mouthwash tablet |
US3888976A (en) * | 1972-09-21 | 1975-06-10 | William P Mlkvy | Zinc and strontium ion containing effervescent mouthwash tablet |
JPS58501675A (ja) * | 1981-10-09 | 1983-10-06 | フエ−リング・ア−ベ− | 物質p「きつ」抗質からなる薬材 |
IT1214611B (it) * | 1985-05-22 | 1990-01-18 | Schiena Ricerche | Composti per uso cosmetico dermatologico e relative composizioni. |
US4837026A (en) * | 1985-10-03 | 1989-06-06 | Rajakhyaksha Vithal J | Transdermal and systemic preparation and method |
US4735802A (en) * | 1986-05-05 | 1988-04-05 | Le Bich N | Topical dermatological composition and method of treatment |
US4986981A (en) * | 1986-07-07 | 1991-01-22 | Den Mat Corporation | Toothpaste having low abrasion |
US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
SE8701372L (sv) * | 1987-04-02 | 1988-10-03 | Boliden Ab | Foerfarande och medel foer konservering av hoe |
DE3929411A1 (de) * | 1988-09-22 | 1990-03-29 | Siegfried Natterer | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung |
CA2014201A1 (fr) * | 1989-04-26 | 1990-10-26 | Albemarle Corporation | Oxydes trialkylamines solides non hydroscopiques |
US5202130A (en) * | 1989-08-31 | 1993-04-13 | The Johns Hopkins University | Suppression of eczematous dermatitis by calcium transport inhibition |
FR2662607B1 (fr) * | 1990-05-30 | 1992-08-28 | Oreal | Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 . |
JPH06509332A (ja) * | 1991-07-05 | 1994-10-20 | メルク シヤープ エンド ドーム リミテツド | 芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用 |
JPH06509090A (ja) * | 1991-07-10 | 1994-10-13 | メルク シヤープ エンド ドーム リミテツド | 芳香族化合物、それらを含む組成物、及び治療におけるそれらの使用 |
GB9201179D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
DE4227203C2 (de) * | 1992-08-17 | 1994-03-24 | Kao Corp Gmbh | Mittel und Verfahren zur Haarbehandlung |
GB9222486D0 (en) * | 1992-10-26 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
CA2148256A1 (fr) * | 1992-10-29 | 1994-05-11 | Ralph M. Hart | Compositions et methodes appropriees pour utilisation a des fins therapeutiques et pharmaceutiques |
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
-
1996
- 1996-03-12 EP EP96400513A patent/EP0737471A3/fr not_active Ceased
- 1996-04-03 NO NO19961371A patent/NO323573B1/no unknown
- 1996-04-09 CA CA002173689A patent/CA2173689C/fr not_active Expired - Fee Related
- 1996-04-10 US US08/630,326 patent/US5851556A/en not_active Expired - Fee Related
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1072355A (en) * | 1964-06-17 | 1967-06-14 | Michael Collin | Antiseptic and anti-pruretic solution containing camphor |
US3519711A (en) * | 1967-09-01 | 1970-07-07 | Robert E Svigals | Composition and method of treating pruritic conditions of the skin |
US4477439A (en) * | 1981-04-13 | 1984-10-16 | Walter J. Monacelli | Treatment of irritated and excoriated areas around the stoma of ostomy patients |
EP0217975A1 (fr) * | 1985-10-08 | 1987-04-15 | Psori-Med Ag | Mélange de sels pour le traitement du psoriasis et autres maladies de la peau |
US5296476A (en) * | 1989-09-08 | 1994-03-22 | Henderson Esther G | Skin care compositions |
EP0451300A1 (fr) * | 1990-04-10 | 1991-10-16 | Romuald Dr. Kowalski | Composition contenant une dispersion colloidale de sulfate de baryum |
DE4315866C1 (de) * | 1993-05-12 | 1994-05-05 | Wogepharm Gmbh | Äußerliche Zubereitungen zur Therapie von Hauterkrankungen mit Photosensibilisatoren |
WO1996019184A1 (fr) * | 1994-12-21 | 1996-06-27 | Cosmederm Technologies | Formulations et procedes pour diminuer l'irritation de la peau |
WO1996019228A1 (fr) * | 1994-12-21 | 1996-06-27 | Cosmederm Technologies | Formulations et procedes pour diminuer l'irritation de la peau |
WO1996019182A1 (fr) * | 1994-12-21 | 1996-06-27 | Cosmederm Technologies | Formulations et procedes pour diminuer l'irritation de la peau |
Also Published As
Publication number | Publication date |
---|---|
EP0737471A2 (fr) | 1996-10-16 |
US5851556A (en) | 1998-12-22 |
CA2173689A1 (fr) | 1996-10-11 |
NO323573B1 (no) | 2007-06-11 |
NO961371L (no) | 1996-10-11 |
CA2173689C (fr) | 2003-10-14 |
NO961371D0 (no) | 1996-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0737471A3 (fr) | Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue | |
CA2167980A1 (fr) | Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue | |
CA2182030A1 (fr) | Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue | |
NO20034751L (no) | Antranilsyreamider, deres fremstilling og anvendelse samt preparater | |
DE69532751D1 (de) | Kosmetische, pharmazeutische oder dermatologische Zusammensetzung, sowie die Zusammensetzung Alpha-TNFAntagonisten enthaltend | |
CA2172777A1 (fr) | Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue | |
DK0957900T3 (da) | Sammensætninger og fremgangsmåder til topisk påföring af terapeutiske midler | |
GB2303629B (en) | Hydroxamic acids and their use as metalloproteinase inhibitors | |
HUP0003583A2 (hu) | Ibuprofen tartalmú gyógyászati szerek | |
TNSN98154A1 (fr) | Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant | |
EP0391002A3 (fr) | Compositions pharmaceutiques contenant de l'acide anthranilique N-(3-4-diméthoxycinnamoyl) | |
ATE245429T1 (de) | Antitrombotische mitteln | |
FR2856294B1 (fr) | Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite | |
HUP9802971A1 (hu) | Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére | |
CA2104677A1 (fr) | Compositions pour administration topique contenant du propionate de fluticasone et de l'oxyconazole ou des sels d'oxyconazole | |
MA26725A1 (fr) | Derives de resorcinol, compositions pharmaceutiques les contenant et procede pour leur preparation | |
BR0115883A (pt) | Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor | |
JP3200187B2 (ja) | チロシナーゼ活性阻害剤 | |
WO2004018044A8 (fr) | Usage therapeutique | |
FR2757391B1 (fr) | Utilisation d'un extrait de la plante terminalia, dans les domaines cosmetique et pharmaceutique, notamment dermatologique | |
ATE168004T1 (de) | Juckreizstillendes mittel | |
US20040023937A1 (en) | Anti-cancer formulation | |
ATE223717T1 (de) | Topisch anzuwendendes abschäumendes arzneimittel zur behandlung von durch pityrosporum ovale verursachten hauterkrankungen | |
PT876144E (pt) | "agentes terapeuticos, contendo ebselen contra a asma" | |
JP2000044459A (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): BE DE DK FR GB IE SE |
|
17P | Request for examination filed |
Effective date: 19960912 |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 7/48 A |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): BE DE DK FR GB IE SE |
|
17Q | First examination report despatched |
Effective date: 20010921 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20031227 |